legislation: 104-hr-3293

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
104-hr-3293 104 hr 3293 Safe Drinking Water Estrogenic Substances Screening Program Act Water Resources Development 1996-04-23 1996-04-26 Referred to the Subcommittee on Health and Environment. House Rep. Lowey, Nita M. [D-NY-18] NY D L000480 12 Safe Drinking Water Estrogenic Substances Screening Program Act - Amends the Safe Drinking Water Act to require the Administrator of the Environmental Protection Agency to develop and, under specified conditions, implement a screening program, using appropriate validated test systems, to determine whether certain substances (including all active and inert ingredients used in registered pesticides) may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen, or such other endocrine effect as the Administrator may designate. Allows the Administrator to exempt a biologic or other substance if the Administrator determines that the substance does not have any effect in humans similar to an effect produced by a naturally occurring estrogen. Requires the Administrator to order a manufacturer of a substance for which such testing is required to conduct such testing and submit results within a certain time period. Provides for suspension of the sale or distribution of the substance if the manufacturer fails to submit required information. Requires the Administrator to: (1) take such action as is necessary to ensure the protection of public health in the case of any substance that is found to have a potential adverse effect on humans; and (2) report findings and recommendations to the Congress. 2025-08-21T20:16:18Z  

Links from other tables